Similarly, the increase in activated CD4+ memory T cells in high‐risk samples could reflect a compensatory immune response to tumour progression, or alternatively, these cells might be indicative of a tumour‐promoting inflammatory environment. The gene discussed is CD4; the disease is neoplasm.